SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending due to concerns over China's potential ban on its AI chips, sparking community debate about its impact and potential for diversification to other markets. Discussions also involve Nvidia's new AI investments in the UK and speculation around rate cuts and their impact on the stock, while community members express concerns about market manipulation and trading strategies amid the volatility.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU.X is trending as community members rally around the project's real-world applications and strong community ethos, emphasizing consistent building and growth. The community is particularly excited about KENDU's unique approach as a permissionless brand and its potential for long-term success. Discussions highlight the dedication of community members and the increasing holder count, with many expressing strong conviction in KENDU's future.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BBAI is trending due to a combination of factors, including a recent disclosure of a Congresswoman's stock purchase and Goldman Sachs increasing its position. The community is discussing potential government contracts and the possibility of a short squeeze, drawing comparisons to other AI-driven stocks. Some are expressing caution, citing past volatility and the need for substantial news to justify the current momentum.

FG Nexus, Inc. engages in the provision of reinsurance, asset management and merchant banking services. The company was founded in October 2012 and is headquartered in Charlotte, NC.

FG Nexus Inc.

Fundamental Global Inc.

Shares of FGNX are volatile amidst a proposed share increase and news of a special distribution of Contingent Value Rights. Community members are weighing the potential impacts of a massive share dilution against the opportunity presented by a substantial dividend payment. Additionally, the company's Ethereum treasury strategy and recent accumulation of ETH are central to the ongoing discussion.

Presidio Property Trust, Inc. is a self-managed real estate investment trust, which invests in a diverse multi-tenant portfolio of real estate assets. It operates through the following segments: Office and Industrial Properties, Model Home Properties, and Retail Properties. The Office and Industrial Properties segment consists of office buildings and an industrial property leased to a variety of tenants ranging from small businesses to large public companies. The Model Home Properties segment consists of model home residential properties leased to homebuilders. The Retail Properties segment includes shopping centers. The company was founded by Jack Kendrick Heilbron on September 28, 1999 and is headquartered in San Diego, CA.

Presidio Property Trust Inc - Ordinary Shares - Class A

Shares of SQFT are surging, driven by discussions of a potential short squeeze due to its low float, with community members pointing to high short interest and a recent offering. Some traders are taking profits, while others anticipate further upside, with speculation around potential price targets. The stock's volatility is attracting attention as traders weigh the possibility of continued momentum against concerns of a potential pump and dump.

StableX Technologies, Inc. engages in the design, development, manufacture, and sale of compact electric fleet solutions for use within urban and short-haul markets. It offers the AYRO 311 and Club Car 411 models. The company was founded on May 19, 2016 and is headquartered in New York, NY.

StableX Technologies Inc.

StableX Technologies, Inc. 

SBLX is trending due to a recent announcement regarding the purchase of FLUID tokens as part of its new stablecoin strategy, with the community actively discussing the potential for a short squeeze given the low float and high borrow rate. Some traders are drawing comparisons to other low-float crypto plays like $QMMM and $CWD, while others express skepticism based on the company's history.

Shineco, Inc. is a holding company, which through its subsidiaries, engages in the production and distribution of plant-based products. It operates through the following segments: Rapid Diagnostic and Other, Other Agricultural, and Healthy Meals Products. The Rapid Diagnostic and Other Products segment is conducted through Biowin, which specializes in the development, production and distribution of innovative rapid diagnostic products and related medical devices for the most common diseases. The Other Agricultural Products segment is conducted through Wintus, which specializes in producing, processing and distribution of agricultural products, such as silk and silk fabrics as well as trading of fresh fruit. The Healthy Meals Products segment is conducted through Fuzhou Meida, which specializes in developing healthy meals for people with slow metabolic health and those in recovery from metabolic disorders. The company was founded on August 20, 1997 and is headquartered in Beijing, China.

Shineco Inc

SISI is trending due to community discussion around a potential short squeeze and high CTB, fueled by good earnings and limited short shares available. Chatter suggests the stock is primed for a significant move, with some highlighting its small float and others pointing to blockchain-related news as a catalyst. Some traders caution about its Chinese origins, while others see a "perfect setup" for gains.

Turbo Energy SA provides energy solutions. It engages in the developing, manufacturing and distributing of photovoltaic products. The company was founded on September 18, 2013 and is headquartered in Valencia, Spain.

Turbo Energy S.A. - ADR

TURB is trending due to a recently announced $53 million energy storage project contract, sparking significant community interest.  Traders are actively discussing its potential for a multi-day run and comparing it to other high-momentum stocks, while also noting its small float and potential short squeeze. The stock's move is attributed to legitimate news, differentiating it from other recent 'crypto treasury pump' driven plays.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending as the quantum computing sector gains momentum, with community members highlighting D-Wave's commercial applications and potential for acquisition by a tech giant. Some investors believe the stock is undervalued compared to its peers, while others are anticipating news from upcoming events like Qubits Japan to act as a catalyst. Discussions also involve potential short squeezes and the impact of interest rate decisions on the stock.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARA is trending as traders discuss its potential as a leveraged Bitcoin play amid crypto market optimism, while some express concerns about management decisions and dilution; community sentiment is mixed, with some anticipating a short squeeze and others remaining bearish due to the company's historical performance and insider selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AXDX Google Accelerate Diagnostics Bankruptcy and you will find a site called &quot;Stretto&quot; that has all of the filings.   Fascinating reading.   Incompetence beyond incompetence.  And the dumbest was likely Indaba who put money into this as a DIP and put out a stalking horse bid. 
 
Bottom line?  MicroGuy was right and I was wrong.   THere was and is no demand for a combined diagnostic blood and isoaltes. 
 
The irony?  BDX liked Pheno!   And Indaba discontinued it!   Had AXDX sold to BDX instead of holding out for Wave it&#39;s likely that Pheno would be part of BDX&#39;s toolbox and AXDX would have avoided bankruptcy. 
 
By the way?  I think this is going to go Chapter 7.

StockTwits Web

Accelerate Diagnostics Inc

 Google Accelerate Diagnostics Bankruptcy and you will find a site called "Stretto" that has all of the filings.   Fascinating reading.   Incompetence beyond incompetence.  And the dumbest was likely Indaba who put money into this as a DIP and put out a stalking horse bid. 
 
Bottom line?  MicroGuy was right and I was wrong.   THere was and is no demand for a combined diagnostic blood and isoaltes. 
 
The irony?  BDX liked Pheno!   And Indaba discontinued it!   Had AXDX sold to BDX instead of holding out for Wave it's likely that Pheno would be part of BDX's toolbox and AXDX would have avoided bankruptcy. 
 
By the way?  I think this is going to go Chapter 7.

Esau McIntosh

@Esau815 I was following along with the bankruptcy filings too. According to the testimony of the Parella Weinberg Partner, they reached out to 18 strategic buyers and conducted MGMT &amp; Due-Diligence meetings with 9 buyers who signed NDAs between Jan - April 2025 before filing CH11 in May. Then during bankruptcy, Parella contacted an additional 21 buyers, 2 who signed  NDAs and got materials and the 9 strategics from  before were contacted again and all declined to put in a bid above the stalking horse DIP creditor
Bid by INDABA. So 11 buyers passed. Indaba gets this whole company for $42M (which was their note/creditor bid). Wild. 

Can’t believe how wrong I was. Worst investment over. Can’t believe this company and the board and C-Suite blew thru $720M on this endeavor since inception. 

Where do you see that Indaba discontinued Pheno? Where does it say BDX was interested in Pheno? Was there an acquisition offer back from 2023 when they signed commercial partnership with BDX?

StockTwits for iOS

 I was following along with the bankruptcy filings too. According to the testimony of the Parella Weinberg Partner, they reached out to 18 strategic buyers and conducted MGMT & Due-Diligence meetings with 9 buyers who signed NDAs between Jan - April 2025 before filing CH11 in May. Then during bankruptcy, Parella contacted an additional 21 buyers, 2 who signed  NDAs and got materials and the 9 strategics from  before were contacted again and all declined to put in a bid above the stalking horse DIP creditor
Bid by INDABA. So 11 buyers passed. Indaba gets this whole company for $42M (which was their note/creditor bid). Wild. 

Can’t believe how wrong I was. Worst investment over. Can’t believe this company and the board and C-Suite blew thru $720M on this endeavor since inception. 

Where do you see that Indaba discontinued Pheno? Where does it say BDX was interested in Pheno? Was there an acquisition offer back from 2023 when they signed commercial partnership with BDX?

Chewey

@cheweyb224 BDX filed a motion to terminate the contract.  In that filing they mentioned that Indaba discontinued Pheno.  They had made a sale of 8 machines in Italy that they could not honor as a result.  That breach caused the filing. 
 
I missed the Perella filing.  Thanks for the update. 
 
My worst investment ever.  At the end of the day?  MicroGuy was right.  There was simply no need for rapid AST.  The BIg Error was believing that BM&#39;s Specific purchase for $430MM set the market and need for AST when in fact it likely showed that doctors didn&#39;t use it and that purchase was a mistake. 
 
AXDX&#39;s biggest error is that they should have sold to BDX when they had the chance.

 BDX filed a motion to terminate the contract.  In that filing they mentioned that Indaba discontinued Pheno.  They had made a sale of 8 machines in Italy that they could not honor as a result.  That breach caused the filing. 
 
I missed the Perella filing.  Thanks for the update. 
 
My worst investment ever.  At the end of the day?  MicroGuy was right.  There was simply no need for rapid AST.  The BIg Error was believing that BM's Specific purchase for $430MM set the market and need for AST when in fact it likely showed that doctors didn't use it and that purchase was a mistake. 
 
AXDX's biggest error is that they should have sold to BDX when they had the chance.

@Esau815 I was also right.  I&#39;m the end user that you mocked for telling you that the product didn&#39;t fit well in a clinical setting.

 I was also right.  I'm the end user that you mocked for telling you that the product didn't fit well in a clinical setting.

Troy Longtin

@troy5190 I have readily admitted that I was disastrously wrong regarding Wave.   I&#39;ve done a mental autopsy.   In the end?  My biggest mistake?   Not recognizing that Biomereiux&#39;s purchase of Specific was indeed a mistake.  I did not have information that Biomerieux&#39;s client base were not making actionable decisions.   Indeed, BDX likely partnered with AXDX to counter that move--and, when seeing that clinicians weren&#39;t using Specific had no interest in acquring AXDX. 
 
As a general rule?  Big money has more credibility than anonymous internet posters.   In this case the general rule was wrong.  Big Money invested in Specific.   Big money invested in AXDX and Selux.   Bottom line?    There&#39;s no need for Rapid AST.

 I have readily admitted that I was disastrously wrong regarding Wave.   I've done a mental autopsy.   In the end?  My biggest mistake?   Not recognizing that Biomereiux's purchase of Specific was indeed a mistake.  I did not have information that Biomerieux's client base were not making actionable decisions.   Indeed, BDX likely partnered with AXDX to counter that move--and, when seeing that clinicians weren't using Specific had no interest in acquring AXDX. 
 
As a general rule?  Big money has more credibility than anonymous internet posters.   In this case the general rule was wrong.  Big Money invested in Specific.   Big money invested in AXDX and Selux.   Bottom line?    There's no need for Rapid AST.

@Esau815 @troy5190  
100% in agreement with you final verdict. 
 
Now, what’s interesting is that there are a couple of dozen companies still trying to bring their ”rapid AST” solutions to the market now. 
 
It’s mind boggling, given the public disclosure as a result of Axdx chapter 11.  
Good read,  nonetheless.

  
100% in agreement with you final verdict. 
 
Now, what’s interesting is that there are a couple of dozen companies still trying to bring their ”rapid AST” solutions to the market now. 
 
It’s mind boggling, given the public disclosure as a result of Axdx chapter 11.  
Good read,  nonetheless.

MicroGuy

My error was  believing that Biomereiux&#39;s purchase of Specific was both necessary and being used and wanted by physicians.    In the end?   Not enough physicians were using Rapid AST to make actionable decisions.   What I thought would be an arms race to compete was basically a wasted purchase and BM&#39;s competitors recognized ust that.   Second biggest loss ever for me. 
 
Lesson learned is to follow sales.   Let&#39;s assume that BDX had a competent sales force.   That they were unable to sell Pheno was telling.   I should have picked up the signs.

My error was  believing that Biomereiux's purchase of Specific was both necessary and being used and wanted by physicians.    In the end?   Not enough physicians were using Rapid AST to make actionable decisions.   What I thought would be an arms race to compete was basically a wasted purchase and BM's competitors recognized ust that.   Second biggest loss ever for me. 
 
Lesson learned is to follow sales.   Let's assume that BDX had a competent sales force.   That they were unable to sell Pheno was telling.   I should have picked up the signs.

@Esau815  
Indeed, purchase of Specific threw off many, including BMX itself - can’t place any units now. 
Big money was wrong here as well.

  
Indeed, purchase of Specific threw off many, including BMX itself - can’t place any units now. 
Big money was wrong here as well.